Sedentary adults at greater risk of cancer mortality
Article written by Bruce Sylvester Physical inactivity is independently associated with an elevated risk of dying from cancer, researchers reported on June 18, 2020 in JAMA Oncology.
Article written by Bruce Sylvester Physical inactivity is independently associated with an elevated risk of dying from cancer, researchers reported on June 18, 2020 in JAMA Oncology.
Article written by Christine Clark Retired GP and researcher Dr Colin Brown realised that the similarities between the ACEI cough and covid-19 cough suggested a common cause and… read more.
Article written by Bruce Sylvester In a study published on August 19, 2020 in the NEJM/New England Journal of Medicine, researchers report successfully treating blocked arteriovenous fistulas with… read more.
Article written by Peter Mas-Mollinedo With the outbreak of the Pandemic and the lingering worries of COVID-19 pharmaceutical sales and marketing has taken a hit. There are no… read more.
Article written by Bruce Sylvester Among patients with a history of heart problems, prediabetes increases risks of heart disease and death, researchers reported on July 15, 2020 in… read more.
One in four older Americans had a virtual medical visit in the first three months of the COVID-19 pandemic, most of them by video, a new telehealth poll… read more.
Article written by Bruce Sylvester By-mail genetic screening, initiated through a primary care physician’s office, can spot otherwise undiagnosed cases of prostate cancer, researchers report in a pilot… read more.
Article written by Gary Finnegan China’s control measures during the first 50 days of the COVID-19 epidemic may have delayed the spread of the virus to cities outside… read more.
Article written by Bruce Sylvester. Current smokers and those with chronic obstructive pulmonary disease COPD suffer greater COVID-19 severity and greater COVID-19 related mortality..
AstraZeneca announced high-level results from Farxiga’s (dapagliflozin) Phase III DAPA-CKD trial showed a statistically significant and clinically meaningful effect on its primary endpoint of a composite of worsening… read more.
Pfizer Inc. and BioNTech SE announced the start of a global (except for China) Phase II/III safety and efficacy clinical study to evaluate a single nucleoside-modified messenger RNA… read more.
AbbVie announced Rinvoq (upadacitinib 15 mg and 30 mg, once daily) plus topical corticosteroids (TCS) met the co-primary endpoints and all secondary endpoints in AD Up, the third… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.